Lawrence I. Golbe, MD received his medical training at New York University School of Medicine and training in internal medicine at Hahnemann University and in neurology at NYU-Bellevue Medical Center. He joined the faculty at UMDNJ-Robert Wood Johnson Medical School in 1983, advancing to Professor in 1997. His principal research interests are progressive supranuclear palsy (PSP) and the genetics and epidemiology of PD. In 1997, Dr. Golbe and collaborators reported that in the Contursi kindred, a family that he had identified and worked up over the previous decade, autosomal-dominant PD was associated with a mutation in the gene for alpha-synuclein. His subsequent resesarch has helped identify genes influencing PD in nonmendelian fashion. Dr. Golbe performed the first study of the prevalence and risk factors in PSP and has chaired the Scientific Advisory Board of the Society for Progressive Supranuclear Palsy since 1992. He has been named by Castle-Connolly and New York Magazine as a "Top Doctor" for the past several years and received the American Parkinson's Disease Association's Fred Springer Award in 2003 in recognition of his research accomplishments.
Associated Grants
-
Epigenetic Regulation of the alpha-synuclein Gene as a Biomarker of Susceptibility to PD
2005